https://www.yiliao.com/index.php?action=history&feed=atom&title=%E5%9F%83%E7%B4%A2%E7%BE%8E%E6%8B%89%E5%94%91 2026-04-19T01:31:53Z 本wiki的该页面的版本历史 MediaWiki 1.35.1 https://www.yiliao.com/index.php?title=%E5%9F%83%E7%B4%A2%E7%BE%8E%E6%8B%89%E5%94%91&diff=305313&oldid=prev 2021-07-21T18:51:08Z

<p>建立内容为“{{Drugbox | Verifiedfields = changed | verifiedrevid = 477167063 | IUPAC_name = (&#039;&#039;S&#039;&#039;)-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)&lt;br /&gt;methylsulfinyl]-3&#039;&#039;…”的新页面</p> <p><b>新页面</b></p><div>{{Drugbox<br /> | Verifiedfields = changed<br /> | verifiedrevid = 477167063<br /> | IUPAC_name = (''S'')-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)&lt;br /&gt;methylsulfinyl]-3''H''-benzoimidazole<br /> | image = esomeprazole.png<br /> | width = 250px<br /> <br /> &lt;!--Clinical data--&gt;<br /> | tradename = Nexium<br /> | Drugs.com = {{drugs.com|monograph|esomeprazole-magnesium}}<br /> | MedlinePlus = a699054<br /> | pregnancy_AU = B3<br /> | pregnancy_US = B<br /> | legal_AU = S4<br /> | legal_UK = POM<br /> | legal_US = Rx-only<br /> | routes_of_administration = Oral, [[Intravenous therapy|IV]]<br /> <br /> &lt;!--Pharmacokinetic data--&gt;<br /> | bioavailability = 50 to 90%<br /> | metabolism = [[Liver|Hepatic]] ([[CYP2C19]], [[CYP3A4]])<br /> | elimination_half-life = 1–1.5 hours<br /> | excretion = 80% [[Kidney|Renal]]&lt;br&gt;20% [[Feces|Faecal]]<br /> <br /> &lt;!--Identifiers--&gt;<br /> | CAS_number_Ref = {{cascite|changed|??}}<br /> | CAS_number = 119141-88-7<br /> | ATC_prefix = A02<br /> | ATC_suffix = BC05<br /> | PubChem = 9579578<br /> | DrugBank_Ref = {{drugbankcite|correct|drugbank}}<br /> | DrugBank = DB00736<br /> | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}<br /> | ChemSpiderID = 7853936<br /> | UNII_Ref = {{fdacite|correct|FDA}}<br /> | UNII = N3PA6559FT<br /> | KEGG_Ref = {{keggcite|correct|kegg}}<br /> | KEGG = D07917<br /> | ChEBI_Ref = {{ebicite|correct|EBI}}<br /> | ChEBI = 50275<br /> | ChEMBL_Ref = {{ebicite|changed|EBI}}<br /> | ChEMBL = 1201320<br /> <br /> &lt;!--Chemical data--&gt;<br /> | C=17 | H=19 | N=3 | O=3 | S=1 <br /> | molecular_weight = 345.417 g/mol<br /> | smiles = COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C<br /> | InChI = 1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m1/s1<br /> | InChIKey = SUBDBMMJDZJVOS-XMMPIXPABO<br /> | StdInChI_Ref = {{stdinchicite|correct|chemspider}}<br /> | StdInChI = 1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m1/s1<br /> | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}<br /> | StdInChIKey = SUBDBMMJDZJVOS-XMMPIXPASA-N<br /> }}<br /> <br /> '''埃索美拉唑'''(英语：Esomeprazole)是[[氢离子帮浦阻断剂]]，商品名为耐适恩(英语：Nexium)；由[[阿斯利康制药|阿斯利康]]研发并在瑞典上市。用于治疗[[消化不良]]、[[消化性溃疡]]、[[胃食道逆流|胃食管反流病]]及柔林格[[症候群]]<br /> <br /> {{阿斯利康制药}}<br /> <br /> [[Category:质子泵抑制剂]] [[Category:胃肠病学]] [[Category:阿斯利康制药]]<br /> ==参考来源==<br /> *[http://zh.wikipedia.org/wiki/%E5%9F%83%E7%B4%A2%E7%BE%8E%E6%8B%89%E5%94%91 维基百科-埃索美拉唑]</div>

123.130.221.191